Logo
GLP-1 RECEPTOR AGONIST MARKET ANALYSIS
  2. / Market Insights
  3. GLP-1 Receptor Agonist Market Analysis
all report title image

GLP-1 RECEPTOR AGONIST MARKET ANALYSIS

GLP-1 Receptor Agonist Market, By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Albiglutide, Semaglutide), By Route of Administration (Parenteral and Oral), By Application (Type 2 Diabetes Mellitus, Obesity, Liver Cirrhosis, Non-alcoholic Steatohepatitis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI4632
  • Pages :170
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

GLP-1 Receptor Agonist Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Eli Lilly and Company
  • Sanofi
  • Novo Nordisk A/S
  • AstraZeneca
  • Perrigo Company PLC
  • 3M Company
  • Bausch Health
  • Taro Pharmaceutical Industries
  • Novan Inc.
  • Serum Institute of India Pvt. Ltd.
  • Orgenesis biotech company
  • Verrica Pharmaceuticals
  • AbbVie Inc.
  • Lee's Pharmaceutical Holdings Ltd
  • Cassiopea
  • Glenmark Pharmaceuticals

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

GLP-1 Receptor Agonist Market to Surpass US$ 55.70 Bn by 2031
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.